New Heart Failure Drug Marketing Costs to Alleviate Novartis’ 2016 Profit
Novartis revealed on Tuesday that the company is boosting its expenditure on marketing a new heart failure drug called Entresto subsequent to disappointing initial sales of the medicine. This increase in expenditure might have a dampening impact on the profit of Novartis in 2016.
The Swiss company explained that this additional expenditure, coupled with decline in sales of leukemia treatment Gleevec, will result in core operating income in 2016 being equivalent to that of 2015 or slightly less than that at constant currencies. Novartis is the biggest prescription drugmaker across the world and its profit in the second quarter was slightly more than the expected level.
The company is relying on its new medications like Entresto and Cosentyx, used in the treatment for psoriasis, to compensate for the adverse impact of generic competition on sales of Gleevec. Entresto was launched in the summer of 2015, but has not been able to experience growth in its most important market of the US, while its sales in Europe are better.
The drug is considered to have enormous potential, with annual sales expectations of $5 billion or more. Its sales reached $32 million during the second quarter, during which sales of Cosentyx was $260 million. Novartis again claimed that it anticipates the sales of Entresto for the full year of 2016 to reach nearly $200 million.
The forecasts for Entresto were enhanced in May after it was strongly recommended for the treatment of heart failure under the new medical guidelines. Joe Jimenez, the Chief Executive Officer of Novartis, aims to benefit from this endorsement by assigning an additional expenditure of $200 million for marketing the medication during the second half of 2016.
The company’s decision to boost expenditure on sales representatives is being supported by industry analysts. "We see this as a necessary spend and one that should have been made earlier", said Tim Race, an analyst at Deutsche Bank.
The process of charging an electric car takes much longer than the conventional process of refueling vehicles with gasoline.
Following Hurricane Irma, normal operations at PortMiami, Fort Lauderdale's Port Everglades and Port Canaveral quickly resumed, but major cruise lines are facing months of disruptions to routes including stoppages at Eastern Caribbean islands that
Following an unanticipated upturn in economic activity in September, the eurozone economy is widely expected to be on track for the best quarter since 2015.
Elon Musk-led electric carmaker Tesla Motors has confirmed that it will discontinue its cheapest version of its Model S e-car, the rear-wheel-drive S60, on coming Sunday.
Motorola’s parent firm Lenovo recently announced the launch of the Moto G5S and G5S Plus smartphones in several markets. The company will shortly share its plan for worldwide launch.
Luxury vehicle maker Volvo has just introduced the 2018 XC40, the company’s latest SUV that looks forward to compete with the Porsche Macan or Range Rover Evoque.